Exane BNP Paribas raised the price target for the Accenture plc (NYSE:ACN) stock from ‘an Outperform’ to ‘a Neutral’. The rating was released on June 29, 2023, according to finviz. The research report from Wolfe Research has reiterated the stock to Peer Perform, with a price target set at $420. The stock was reiterated by UBS, who disclosed in a research note on December 17, 2021, to Neutral and set the price objective to $397. In their research brief published December 17, 2021, Deutsche Bank analysts reiterated the Accenture plc stock to Buy with a price target of $440.